Eric Deroo, MD
Urology · Overland Park, KSNPI 1922395938
Payments from drug & device makers
Across 21 payments — averaging $90.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Teleflex LLC$577
- AstraZeneca$35
- C. R. Bard, Inc. & Subsidiaries$33
- Rochester Medical Corporation$18
- 180 Medical, Inc.$18
- plus $24 from 2 others
What the payments were for
- Travel & lodging$1,56582%
- Food & beverage$29816%
- Education$352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $1,193 |
| Teleflex LLC | 4 | $577 |
| AstraZeneca | 1 | $35 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $33 |
| Rochester Medical Corporation | 1 | $18 |
| 180 Medical, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS$939
- UroLift System$545
How this compares
$1,898 in reported general payments places this provider in the 40th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 224 | $144,596 |
| GemtesaVibegron | 27 | $19,083 |
| Solifenacin Succinate | 204 | $6,373 |
| Methenamine Hippurate | 98 | $6,285 |
| Tamsulosin Hcl | 424 | $5,590 |
| Trospium Chloride ErTrospium Chloride | 35 | $3,772 |
| Mirabegron ErMirabegron | 11 | $3,641 |
| Trospium Chloride | 104 | $3,296 |
| Estradiol | 52 | $3,228 |
| Cefpodoxime Proxetil | 24 | $2,422 |
| Finasteride | 190 | $2,286 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 20 | $1,644 |
| Silodosin | 38 | $1,560 |
| Potassium Citrate ErPotassium Citrate | 19 | $1,122 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 39 | $582 |
Paid to pharmacies, not to this prescriber.
Other urology in Overland Park
- Jason AnastOverland Park$31K
- Christian HettingerOverland Park$14K
- Nathaniel BallekOverland Park$11K
- Mirian BociOverland Park$7K
- Andrew FlumOverland Park$6K
- David BockOverland Park$6K
- Andrew MorrisOverland Park$6K
- Lindsay HertzigOverland Park$3K
- Bradley DavisOverland Park$3K
- Son NguyenMerriam$6.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.